Anne Schmechtig, PhD
Affiliations: | Neuroimaging | Institute of Psychiatry, Charleston, SC, United States |
Google:
"Anne Schmechtig"Mean distance: 20.44 (cluster 42) | S | N | B | C | P |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Kumari V, Antonova E, Wright B, et al. (2016) The mindful eye: Smooth pursuit and saccadic eye movements in meditators and non-meditators. Consciousness and Cognition. 48: 66-75 |
| Koychev I, Joyce D, Barkus E, et al. (2016) Cognitive and oculomotor performance in subjects with low and high schizotypy: implications for translational drug development studies. Translational Psychiatry. 6: e811 |
| Kumari V, Ettinger U, Lee SE, et al. (2015) Common and distinct neural effects of risperidone and olanzapine during procedural learning in schizophrenia: a randomised longitudinal fMRI study. Psychopharmacology |
| Schmechtig A, Lees J, Perkins A, et al. (2013) The effects of ketamine and risperidone on eye movement control in healthy volunteers. Translational Psychiatry. 3: e334 |
| Perkins AM, Ettinger U, Weaver K, et al. (2013) Advancing the defensive explanation for anxiety disorders: lorazepam effects on human defense are systematically modulated by personality and threat-type. Translational Psychiatry. 3: e246 |
| Schmechtig A, Lees J, Grayson L, et al. (2013) Effects of risperidone, amisulpride and nicotine on eye movement control and their modulation by schizotypy. Psychopharmacology. 227: 331-45 |
| Koychev I, McMullen K, Lees J, et al. (2013) Differential effect of amisulpride on cognition in schizotypy: validation of models for the early identification of cognitive enhancing agents The Lancet. 381: 59-59 |
| Owens SF, Picchioni MM, Ettinger U, et al. (2012) Prefrontal deviations in function but not volume are putative endophenotypes for schizophrenia. Brain : a Journal of Neurology. 135: 2231-44 |
| Völter C, Riedel M, Wöstmann N, et al. (2012) Sensorimotor gating and D2 receptor signalling: evidence from a molecular genetic approach. The International Journal of Neuropsychopharmacology / Official Scientific Journal of the Collegium Internationale Neuropsychopharmacologicum (Cinp). 15: 1427-40 |
| Koychev I, McMullen K, Lees J, et al. (2012) A validation of cognitive biomarkers for the early identification of cognitive enhancing agents in schizotypy: a three-center double-blind placebo-controlled study. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 22: 469-81 |